Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study)

INTRODUCTION: Idiopathic nephrotic syndrome (INS) is characterised by a high relapse rate up to 80% after initial response to standard therapy with corticosteroids. Steroid toxicity is common and causes a great burden of disease that negatively influences the health-related quality of life (HRQoL)....

Descripción completa

Detalles Bibliográficos
Autores principales: Veltkamp, Floor, Khan, Djera H, Reefman, Christa, Veissi, Susan, van Oers, Hedy A, Levtchenko, Elena, Mathôt, Ron A A, Florquin, Sandrine, van Wijk, Joanna A E, Schreuder, Michiel F, Haverman, Lotte, Bouts, Antonia H M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688689/
https://www.ncbi.nlm.nih.gov/pubmed/31375606
http://dx.doi.org/10.1136/bmjopen-2018-027011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688689/
https://www.ncbi.nlm.nih.gov/pubmed/31375606
http://dx.doi.org/10.1136/bmjopen-2018-027011

Ejemplares similares